Hanmi Pharmaceuticals

**Hanmi Pharmaceuticals** is a prominent South Korean pharmaceutical company that has been serving the industry since its establishment in **1973**. With a wide array of over 200 products sold globally, Hanmi has solidified its position as a major player not only in Korea but also within the region. Notably, the company is acknowledged as the **No.1 R&D investing company in Korea**, allocating a considerable **10-15%** of its annual revenue to the development of next-generation Platform Technologies & NCE products.

With its headquarters situated in **Seoul, South Korea**, Hanmi Pharmaceuticals continues to strive for excellence in the pharmaceutical sector. The company's unwavering dedication to innovation and advancement is encapsulated in its slogan, which translates to "Endless challenges for the pharmaceutical powerhouse, a new pledge."

For potential investors seeking an opportunity to collaborate with a progressive and innovative pharmaceutical entity, Hanmi Pharmaceuticals presents an exciting prospect. For further details on Hanmi Pharmaceutical's operations and offerings, please visit their website at www.hanmipharm.com.